ESMYX | VESIX | ESMYX / VESIX | |
Total Expense Ratio | 1.20 | 0.06 | 2,000% |
Annual Report Gross Expense Ratio | 1.21 | 0.06 | 2,017% |
Fund Existence | 17 years | 25 years | - |
Gain YTD | 6.652 | 8.888 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 157M | 28B | 1% |
Annual Yield % from dividends | 5.05 | 3.16 | 160% |
Returns for 1 year | 4.66 | 7.29 | 64% |
Returns for 3 years | 5.57 | 13.37 | 42% |
Returns for 5 years | 58.37 | 53.99 | 108% |
Returns for 10 years | 50.59 | 28.35 | 178% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EFG | 99.22 | 0.96 | +0.98% |
iShares MSCI EAFE Growth ETF | |||
CMDY | 50.10 | 0.12 | +0.23% |
iShares Blmbrg Roll Sel Cmdty Strart ETF | |||
IGI | 16.12 | -0.01 | -0.06% |
Western Asset Investment Grade Opportunity Trust Inc | |||
HQH | 15.10 | -0.01 | -0.07% |
abrdn Healthcare Investors | |||
GRN | 25.66 | -0.38 | -1.46% |
iPath® Series B Carbon ETN |